Publications by authors named "Gaetano Lanza"

Background: In acute heart failure (AHF) patients, non-invasive estimation of left ventricular filling pressures (LVFPs) appears crucial to guide management. Although poorly investigated, left atrial (LA) mechanics play a pivotal role in this setting. This report sought to assess the correlation of echocardiographic LA stiffness index with invasive LVFPs and its diagnostic accuracy as compared to other parameters used in clinical practice.

View Article and Find Full Text PDF
Article Synopsis
  • Coronary microvascular dysfunction (CMD) is significant beyond chronic coronary syndromes (CCS) and has important implications for heart health and treatment strategies.
  • CMD can be detected using safe, non-invasive methods and is linked to various heart conditions, including heart failure and Takotsubo syndrome, even without the presence of obstructive coronary artery disease.
  • Understanding CMD patterns outside of CCS may help identify disease progression and improve treatment response, acting as a warning sign for adverse cardiac changes.
View Article and Find Full Text PDF
Article Synopsis
  • This text refers to a correction made to an article identified by its DOI (Digital Object Identifier) 10.15420/ecr.2024.03.
  • The correction is likely aimed at addressing inaccuracies or clarifying information presented in the original article.
  • Such corrections are important in academic publishing to maintain the reliability and integrity of scientific literature.
View Article and Find Full Text PDF

Catheter ablation (CA) is a well-established treatment in patients with ventricular tachycardia and appropriate implantable cardioverter defibrillator (ICD) therapies. We enrolled 57 consecutive carriers of ICD undergoing CA for electrical storm (ES). Our aim was to investigate differences in clinical, device-related, and electroanatomic features among patients who had history of appropriate ICD interventions before the ES compared to those who had not.

View Article and Find Full Text PDF

Background: Evidence about early cardiac mechanics abnormalities in patients with mitochondrial diseases (MDs) before overt cardiomyopathy is limited.

Methods: In this prospective study, we performed a comparative analysis of conventional and speckle tracking echocardiographic parameters between patients with genetically identified MDs and no overt cardiomyopathy vs controls matched for age, sex and cardiovascular risk factors. The Newcastle mitochondrial disease adult scale (NMDAS) was calculated, using a threshold of > 21 as indicator of high disease severity.

View Article and Find Full Text PDF

Background: Detection of myocardial bridge (MB) at angiography suggests it has a role in ischaemic-related symptoms in patients with angina without obstructive coronary artery disease. However, evidence that MB may cause myocardial ischaemia is limited.

Methods: We studied 41 patients with MB of the left anterior descending coronary artery and otherwise normal coronary arteries.

View Article and Find Full Text PDF
Article Synopsis
  • Iron deficiency (ID) is prevalent in heart failure (HF) patients and negatively impacts their health, even if they aren't anemic; iron supplementation can improve exercise and quality of life in these individuals.
  • An online survey of 256 cardiologists revealed that most defined ID correctly and screened more than half of their patients, but only 54.3% did periodic screenings; intravenous iron was the most commonly prescribed treatment.
  • The survey results point to a need for better, standardized practices for ID screening and management in HF patients, as many physicians view ID as an overlooked issue in this group.
View Article and Find Full Text PDF

Sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new drug class initially designed and approved for treatment of diabetes mellitus, have been shown to exert pleiotropic metabolic and direct cardioprotective and nephroprotective effects that extend beyond their glucose-lowering action. These properties prompted their use in two frequently intertwined conditions, heart failure and chronic kidney disease. Their unique mechanism of action makes SGLT2i an attractive option also to lower the rate of cardiac events and improve overall survival of oncological patients with preexisting cardiovascular risk and/or candidate to receive cardiotoxic therapies.

View Article and Find Full Text PDF
Article Synopsis
  • Intracoronary acetylcholine testing can trigger coronary artery spasms in patients with angina but non-obstructive coronary artery disease, although individual impacts are unclear.
  • This study involved 81 patients categorized into three groups (CAS, CMVS, and NEG) based on testing responses, and all underwent exercise stress tests before and after nitrate administration.
  • Results indicated no significant differences in stress test outcomes across groups, suggesting that both coronary spasms may similarly affect exercise-induced angina and ischemia.
View Article and Find Full Text PDF
Article Synopsis
  • The CARdio-Tox study investigated the cardiovascular complications associated with Chimeric Antigen Receptor-T (CAR-T) cell therapy, particularly focusing on the incidence of cancer therapy-related cardiac dysfunction (CTRCD) amidst cytokine release syndrome (CRS).* -
  • Patients with blood malignancies underwent echocardiography before and at 7 and 30 days post-CAR-T infusion, revealing a high CTRCD incidence of 59.3% at 7 days, especially in those experiencing CRS.* -
  • The study found significant correlations between early declines in heart function metrics and inflammatory markers, emphasizing the need for ongoing patient monitoring to address potential cardiac issues related to CAR-T therapy.*
View Article and Find Full Text PDF
Article Synopsis
  • The study looked at how to identify problems in patients with certain heart issues using a test called acetylcholine (ACh) provocation testing.
  • Researchers created a score called the ABCD score to help predict if patients would have a positive test result based on specific factors.
  • The ABCD score could help reduce unnecessary testing for patients with high scores, making treatments safer and more efficient, but more research is needed to confirm its effectiveness.
View Article and Find Full Text PDF

Background: Fabry disease (FD) and transthyretin cardiac amyloidosis (TTR CA) are cardiomyopathies with hypertrophic phenotype that share several features, including left atrial (LA) enlargement and dysfunction, but direct comparative data are lacking. Aim of the present study was to perform a comparative analysis of LA remodelling between the two diseases.

Methods And Results: In this prospective study, a total of 114 patients (31 FD and 83 TTR CA) were included; all of them had left ventricular hypertrophy (LVH), defined as left ventricular (LV) wall thickness ≥ 12 mm.

View Article and Find Full Text PDF

Background: Transcatheter aortic valve implantation (TAVI) has become a largely used treatment for severe aortic stenosis. There are limited data, however, about predictors of long-term prognosis in this population. In this study, we assessed whether ventricular arrhythmias may predict clinical outcomes in patients undergoing TAVI.

View Article and Find Full Text PDF

Aims: Both hyperglycaemia and large glycaemic variability are associated with worse outcomes in patients with Type 2 diabetes mellitus (T2DM), possibly causing sympatho-vagal imbalance and endothelial dysfunction. Continuous subcutaneous insulin injection (CSII) improves glycemic control compared to multiple daily insulin injections (MDI). We aimed to assess whether CSII may improve cardiac autonomic and vascular dilation function compared to MDI.

View Article and Find Full Text PDF

Background: Previous studies showed that exercise may increase cardiac troponin serum levels; whether the occurrence of myocardial ischemia influences the changes of exercise-induced troponin raise, however, remains debatable.

Methods: We prospectively enrolled consecutive patients undergoing for the first time an elective stress myocardial perfusion scintigraphy (MPS) because of clinical suspicion of obstructive coronary artery disease (CAD). Patients were divided into 3 groups based on the evidence and degree of stress-induced myocardial ischemia at MPS: 1) group 1, no myocardial ischemia (≤4 %); 2) group 2, mild myocardial ischemia (5-10 %); 3) group 3, moderate-to-severe myocardial ischemia (≥10 %).

View Article and Find Full Text PDF

Objective: Despite the publication of various national/international guidelines, several questions concerning the management of patients with asymptomatic (AsxCS) and symptomatic (SxCS) carotid stenosis remain unanswered. The aim of this international, multi-specialty, expert-based Delphi Consensus document was to address these issues to help clinicians make decisions when guidelines are unclear.

Methods: Fourteen controversial topics were identified.

View Article and Find Full Text PDF
Article Synopsis
  • A recent update was made about how to manage patients with asymptomatic carotid stenosis (AsxCS), which means they have a narrow artery but don’t show symptoms.
  • Researchers looked at studies until August 2023 to learn about new treatments and techniques for these patients.
  • It's important to provide medical treatment to all patients, but some with specific risks may need surgery, and decisions should be based on individual needs and situations.
View Article and Find Full Text PDF

Recently, prognosis and survival of cancer patients has improved due to progression and refinement of cancer therapies; however, cardiovascular sequelae in this population augmented and now represent the second cause of death in oncological patients. Initially, the main issue was represented by heart failure and coronary artery disease, but a growing body of evidence has now shed light on the increased arrhythmic risk of this population, atrial fibrillation being the most frequently encountered. Awareness of arrhythmic complications of cancer and its treatments may help oncologists and cardiologists to develop targeted approaches for the management of arrhythmias in this population.

View Article and Find Full Text PDF

Calcium channel blockers (CCBs) are the first-line treatment for coronary artery spasm (CAS). When CAS-related angina symptoms are not well controlled by CCB therapy, long-acting nitrates or (where available) nicorandil can be added as second-line medications. In the case of CAS refractory to standard treatments, several other alternative drugs and interventions have been proposed, including the Rho-kinase inhibitor fasudil, anti-adrenergic drugs, neural therapies and percutaneous coronary interventions.

View Article and Find Full Text PDF
Article Synopsis
  • The review focused on gathering the latest information about anesthesia and other medical practices for a surgery called carotid endarterectomy.
  • They examined many studies from specific medical databases to find the best practices and results.
  • The findings suggested that using any anesthesia and checking brain function during surgery can help patients do better, but there wasn't enough proof on whether to reverse a medicine called heparin after surgery. They also mentioned keeping an eye on blood pressure after surgery, even though the evidence was weak.
View Article and Find Full Text PDF
Article Synopsis
  • A recent study observed the effects of the drug Sacubitril/Valsartan on patients with heart failure and reduced ejection fraction (HFrEF), indicating significant improvements in heart function over 12 months.
  • Researchers analyzed echocardiographic data from 66 patients, finding that changes in left ventricular global longitudinal strain (LVGLS) and left atrial reservoir strain (LARS) after three months were key predictors of long-term recovery in heart function.
  • The results suggest that measuring LV and LA strain should become a standard part of assessing treatment effectiveness in HFrEF patients.
View Article and Find Full Text PDF

Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous group of clinical entities characterized by clinical evidence of acute myocardial infarction (AMI) with normal or near-normal coronary arteries on coronary angiography (stenosis < 50%) and without an over the alternative diagnosis for the acute presentation. Its prevalence ranges from 6% to 11% among all patients with AMI, with a predominance of young, nonwhite females with fewer traditional risks than those with an obstructive coronary artery disease (MI-CAD). MINOCA can be due to either epicardial causes such as rupture or fissuring of unstable nonobstructive atherosclerotic plaque, coronary artery spasm, spontaneous coronary dissection and cardioembolism in-situ or microvascular causes.

View Article and Find Full Text PDF

Background: Cardiovascular (CV) diseases are a cause of increased long-term morbidity and mortality in childhood cancer survivors (CCSs) treated with anthracyclines. These drugs may affect not only the heart, but also the vascular system. Left ventricular-arterial coupling (LVAC) represents a reliable parameter of altered ventricular and vascular performance, with validated prognostic value and never investigated in this setting.

View Article and Find Full Text PDF

Aims: The aim of our study is to assess the ability of left atrial (LA) strain values to improve left ventricular and diastolic pressure (LVEDP) non-invasive estimation as compared with traditional echocardiographic indexes in the acute phase of Takotsubo syndrome (TTS) and to predict adverse in-hospital outcomes in this population.

Methods And Results: Consecutive TTS patients were prospectively enrolled. Left ventricular and diastolic pressure was measured at the time of catheterization.

View Article and Find Full Text PDF